Literature DB >> 2449501

Cytolysis of tumor necrosis factor (TNF)-resistant tumor targets. Differential cytotoxicity of monocytes activated by the interferons, IL-2, and TNF.

R Philip1.   

Abstract

Herein we demonstrate that IFN-alpha, IFN-gamma, and IL-2 can induce human peripheral blood monocyte-mediated lysis of tumor cells that are resistant to both the direct effects of TNF and to monocytes activated by TNF. Monocytes activated by TNF kill only TNF-sensitive tumor targets, whereas those activated by IFN and IL-2 can lyse both TNF-sensitive and TNF-resistant tumor targets. Monocyte cytotoxicity against TNF-sensitive lines induced by the IFN, IL-2, or TNF can be completely abrogated by the addition of anti-TNF antibodies. In contrast, anti-TNF antibodies have no effect on IFN- or IL-2-induced monocyte cytotoxicity against TNF resistant targets, confirming non-TNF-mediated lysis induced by lymphokine-activated monocytes. Neither induction of TNF receptors by IFN-gamma nor inhibition of RNA synthesis by actinomycin D increased the susceptibility of TNF-resistant tumor targets to TNF-mediated monocyte cytotoxicity. Thus, non-TNF-mediated modes of monocyte cytotoxicity are induced by IFN and IL-2, but not by TNF, indicating that different cytotoxic mechanisms are responsible for the lysis of TNF-sensitive and TNF-resistant tumor cells. In addition, these findings also suggest that TNF-sensitive lines are susceptible only to TNF-mediated killing and apparently insensitive to non-TNF-mediated monocyte cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2449501

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

Review 1.  Exercising in environmental extremes : a greater threat to immune function?

Authors:  Neil P Walsh; Martin Whitham
Journal:  Sports Med       Date:  2006       Impact factor: 11.136

2.  Mononuclear phagocytes from human bone marrow progenitor cells; morphology, surface phenotype, and functional properties of resting and activated cells.

Authors:  R Keller; R Keist; P Joller; P Groscurth
Journal:  Clin Exp Immunol       Date:  1993-01       Impact factor: 4.330

3.  The augmentation of lymphokine-activated killer activity following pulsing of human peripheral blood mononuclear cells with recombinant human interleukin-2.

Authors:  C R Carter; B W Hancock; R C Rees
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

4.  Enhancement of the antibody-dependent tumoricidal activity of human monocytes by human monocytic colony-stimulating factor.

Authors:  S Suzu; N Yanai; M Saito; T Kawashima; T Kasahara; M Saito; F Takaku; K Motoyoshi
Journal:  Jpn J Cancer Res       Date:  1990-01

5.  Possible stimulation of anti-tumor immunity using repeated cold stress: a hypothesis.

Authors:  Nikolai A Shevchuk; Sasa Radoja
Journal:  Infect Agent Cancer       Date:  2007-11-13       Impact factor: 2.965

6.  Leukemic cell lysis by activated human macrophages: significance of membrane-associated tumor necrosis factor.

Authors:  Y Nakabo; N Harakawa; K Yamamoto; M Okuma; K Uno; M Sasada
Journal:  Jpn J Cancer Res       Date:  1993-11

7.  Lysis of human leukemic cells by monocyte-derived macrophages activated with interferon-gamma and interleukin-2.

Authors:  T Kakita; M Sasada; T Moriguchi; T Nishimura; K Yamamoto; H Uchino
Journal:  Jpn J Cancer Res       Date:  1989-01

8.  Inhibition by sphingosine of leukemic cell killing by human monocytes activated with interleukin-2: a possible role of protein kinase C.

Authors:  Y Nakabo; M J Pabst
Journal:  Jpn J Cancer Res       Date:  1998-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.